HomeCompareOBSOX vs JNJ

OBSOX vs JNJ: Dividend Comparison 2026

OBSOX yields 6.90% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OBSOX wins by $11.5K in total portfolio value
10 years
OBSOX
OBSOX
● Live price
6.90%
Share price
$28.99
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.6K
Annual income
$1,069.39
Full OBSOX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — OBSOX vs JNJ

📍 OBSOX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOBSOXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OBSOX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OBSOX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OBSOX
Annual income on $10K today (after 15% tax)
$586.41/yr
After 10yr DRIP, annual income (after tax)
$908.98/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, OBSOX beats the other by $205.37/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OBSOX + JNJ for your $10,000?

OBSOX: 50%JNJ: 50%
100% JNJ50/50100% OBSOX
Portfolio after 10yr
$25.8K
Annual income
$948.59/yr
Blended yield
3.68%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

OBSOX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OBSOX buys
0
JNJ buys
0
No recent congressional trades found for OBSOX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOBSOXJNJ
Forward yield6.90%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$31.6K$20.0K
Annual income after 10y$1,069.39$827.78
Total dividends collected$8.8K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: OBSOX vs JNJ ($10,000, DRIP)

YearOBSOX PortfolioOBSOX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,390$689.89$10,676$355.77+$714.00OBSOX
2$12,922$734.37$11,407$389.39+$1.5KOBSOX
3$14,605$778.63$12,198$426.53+$2.4KOBSOX
4$16,450$822.48$13,056$467.62+$3.4KOBSOX
5$18,467$865.76$13,987$513.12+$4.5KOBSOX
6$20,668$908.35$14,998$563.56+$5.7KOBSOX
7$23,065$950.11$16,098$619.52+$7.0KOBSOX
8$25,670$990.93$17,295$681.69+$8.4KOBSOX
9$28,498$1,030.71$18,599$750.82+$9.9KOBSOX
10$31,562$1,069.39$20,022$827.78+$11.5KOBSOX

OBSOX vs JNJ: Complete Analysis 2026

OBSOXStock

The fund invests normally at least 80% of its net assets in the securities of small-cap companies. Its investment adviser considers small-cap companies as those, at the time of initial investment, with a market capitalization of less than $5 billion or with a market capitalization within the range of the holdings of the Russell 2000 Index. The fund invests principally in the common stocks of companies that the adviser believes have the potential for significant long-term growth in market value. It invests in those companies which the adviser considers to have above-average long-term growth potential.

Full OBSOX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this OBSOX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OBSOX vs SCHDOBSOX vs JEPIOBSOX vs OOBSOX vs KOOBSOX vs MAINOBSOX vs ABBVOBSOX vs MRKOBSOX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.